Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ascendis Pharma A/S

166.05
+1.400.85%
Post-market: 166.050.00000.00%16:56 EDT
Volume:315.57K
Turnover:51.91M
Market Cap:9.94B
PE:-24.56
High:166.86
Open:164.29
Low:161.01
Close:164.65
Loading ...

Ascendis Pharma a/S : Jefferies Raises Target Price to $194 From $191

THOMSON REUTERS
·
17 Dec 2024

Ascendis Pharma (ASND) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
17 Dec 2024

Analysts Offer Insights on Healthcare Companies: Larimar Therapeutics (LRMR) and Ascendis Pharma (ASND)

TIPRANKS
·
17 Dec 2024

European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading

MT Newswires Live
·
17 Dec 2024

Ascendis Pharma announces results from New InsiGHTS tril of TransCon hGH

TIPRANKS
·
16 Dec 2024

Ascensis Pharma Says FDA Will Review Application for Adult Treatment of Growth Hormone Deficiency

Dow Jones
·
13 Dec 2024

Ascendis Pharma's Supplemental BLA for Adult Growth Hormone Deficiency Drug Accepted by FDA

MT Newswires Live
·
13 Dec 2024

European Equities Traded in the US as American Depositary Edge Higher in Wednesday Trading

MT Newswires Live
·
12 Dec 2024

Morgan Stanley Sticks to Its Hold Rating for Ascendis Pharma (ASND)

TIPRANKS
·
25 Nov 2024

European Equities Traded in the US as American Depositary Rise in Friday Trading, Up Over 1% for Week

MT Newswires Live
·
23 Nov 2024

Ascendis Pharma a/S : Citigroup Cuts Target Price to $200 From $207

THOMSON REUTERS
·
18 Nov 2024

Ascendis Pharma Is Maintained at Buy by TD Cowen

Dow Jones
·
16 Nov 2024

European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week

MT Newswires Live
·
16 Nov 2024

Ascendis Pharma Price Target Maintained With a $170.00/Share by Cantor Fitzgerald

Dow Jones
·
15 Nov 2024

Stock Track | Ascendis Pharma Soars 5.4% on Positive Analyst Views and Earnings Beat

Stock Track
·
15 Nov 2024

Bank of America Securities Sticks to Its Buy Rating for Ascendis Pharma (ASND)

TIPRANKS
·
15 Nov 2024